These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6753612)

  • 1. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
    Breuning SE; Davis VJ; Matson JL; Ferguson DG
    Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in young mentally retarded individuals.
    Gualtieri CT; Schroeder SR; Hicks RE; Quade D
    Arch Gen Psychiatry; 1986 Apr; 43(4):335-40. PubMed ID: 2869741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of single-double blind procedures, maintenance of placebo effects and drug induced dyskinesia with mentally retarded persons.
    Breuning SE; Ferguson DG; Cullari S
    Appl Res Ment Retard; 1980; 1(3-4):175-92. PubMed ID: 7337456
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of phenytoin withdrawal on matching to sample and workshop performance of mentally retarded persons.
    Davis VJ; Poling AD; Wysocki T; Breuning SE
    J Nerv Ment Dis; 1981 Nov; 169(11):718-25. PubMed ID: 7299384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thioridazine on the intellectual performance of mentally retarded drug responders and nonresponders.
    Breuning SE; Ferguson DG; Davidson NA; Poling AD
    Arch Gen Psychiatry; 1983 Mar; 40(3):309-13. PubMed ID: 6338856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relapse of aggressive and disruptive behavior in mentally retarded adults following antipsychotic drug withdrawal predicts psychotropic drug use a decade later.
    Janowsky DS; Barnhill LJ; Khalid AS; Davis JM
    J Clin Psychiatry; 2006 Aug; 67(8):1272-7. PubMed ID: 16965207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical evaluation of mesoridazine in mentally retarded patients.
    Zaleski W
    Can Psychiatr Assoc J; 1970 Jun; 15(3):319-22. PubMed ID: 4913609
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the clinical outcome of patients with profound mental retardation gradually withdrawn from chronic neuroleptic medication.
    May P; London EB; Zimmerman T; Thompson R; Mento T; Spreat S
    Ann Clin Psychiatry; 1995 Dec; 7(4):155-60. PubMed ID: 8721888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyskinesias subside off all medication in a boy with autistic disorder and severe mental retardation.
    Brasić JR; Barnett JY; Aisemberg P; Ahn SC; Nadrich RH; Kaplan D; Ahmad R; Mendonça Mde F
    Psychol Rep; 1997 Dec; 81(3 Pt 1):755-67. PubMed ID: 9400068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of withdrawal dyskinesia.
    Gardos G
    Am J Psychiatry; 1979 Aug; 136(8):1099. PubMed ID: 464147
    [No Abstract]   [Full Text] [Related]  

  • 13. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents.
    Aman MG; White AJ
    J Autism Dev Disord; 1988 Sep; 18(3):355-66. PubMed ID: 3170454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of single, double-blind procedures, maintenance of placebo effects, and drug-induced dyskinesia with mentally retarded persons--a brief report [proceedings].
    Breuning SE; Ferguson DG; Cullari S
    Psychopharmacol Bull; 1981 Jan; 17(1):122-3. PubMed ID: 7232641
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of phenytoin withdrawal on matching to sample and workshop performance of mentally retarded individuals--a brief report.
    Davis VJ
    Psychopharmacol Bull; 1982 Jan; 18(1):51-4. PubMed ID: 6965200
    [No Abstract]   [Full Text] [Related]  

  • 16. Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia?
    Faheem AD; Brightwell DR; Burton GC; Struss A
    Am J Psychiatry; 1982 Apr; 139(4):517-8. PubMed ID: 6121492
    [No Abstract]   [Full Text] [Related]  

  • 17. An applied dose-response curve of thioridazine with the mentally retarded: aggressive, self-stimulatory, intellectual, and workshop behaviors--a preliminary report.
    Breuning SE
    Psychopharmacol Bull; 1982 Jan; 18(1):57-9. PubMed ID: 6965201
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of picture prompts on the acquisition of complex vocational tasks by mentally retarded adolescents.
    Wacker DP; Berg WK
    J Appl Behav Anal; 1983; 16(4):417-33. PubMed ID: 6654772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tourette-like syndrome following low dose short-term neuroleptic treatment.
    Lal S; AlAnsari E
    Can J Neurol Sci; 1986 May; 13(2):125-8. PubMed ID: 3459568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo treatment-resistant psychosis following thioridazine withdrawal.
    Bastiampillai T; Fantasia R; Nelson A
    Aust N Z J Psychiatry; 2014 Jun; 48(6):585-6. PubMed ID: 23908310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.